May 14, 2025
Quva Adds a New, Forward Distribution Center to Its Industry Leading Integrated 503B and Data Services Platform
Jul 25, 2024
QuVa Pharma Completes Acquisition of LogicStream Health Combination Creates Integrated Platform of Compounded Medications, Distribution Services, and AI-Powered Data Solutions
Oct 28, 2020
QuVa Pharma Expands Its Partnership With Kit Check(TM) to Help Hospitals Improve Medication Management and Automation Through RFID Tagging
Oct 15, 2020
QuVa Pharma® Announces Availability of Intravenous Dexamethasone to Support Hospitalized COVID-19 Patients
Sep 10, 2020
The Compounding Quality Coalition Commends the FDA for its Continued Commitment of Protecting Public Health
May 13, 2020
QuVa Pharma® Prepared For Increased Output Of Sterile Compounding Of Essential Medicines For COVID-19 Crisis
Dec 09, 2019
QuVa Pharma® Launches Cardioplegia Offering through a Compounding and Distribution Agreement with Hibernation Therapeutics for Adenocaine(TM) Solution
Nov 11, 2019
QuVa Pharma Announces New, Innovative Syringe Labels
Dec 13, 2018
QuVa Pharma awarded National Outsourced I.V. Admixture Services Agreement with Premier
Sep 26, 2018
QuVa Pharma Announces Significant New Production Capacity Is Now Operational
Jul 24, 2018
Eyeing The Future, QuVa Pharma Announces Successful Capital Raise
Mar 06, 2018
QuVa Pharma in Training Program for First Responders in Terror Events
Jan 31, 2018
Amid Rapid Growth, QuVa Pharma Announces New Equity and Debt Funding
Sep 26, 2017
QuVa Pharma Announces FDA 503B Registration of its New Jersey Facility
Jul 05, 2017
QuVa Pharma Announces Licensure under California's SBOP New 503B Outsource License Category
Jun 20, 2017
QuVa Pharma Announces Availability of Sodium Bicarbonate Syringe